Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
A: 46 weeks refrigerated with BAC water
Bariatric surgery Weight loss surgery is a safe and common approach to addressing obesity
White Bottle GLP-1 Category Capsule Packaging for Private Label Brands This white bottle packaging direction helps overseas buyers discuss label style, bottle color, capsule count, MOQ planning, and claim-review workflow before sampling
TIRZEPATIDE/ZEPBOUND Once-weekly injection SURMOUNT-1 Trial: Over 20% mean body weight reduction at higher doses Greater likelihood of 15% body weight reduction Newer drug with less overall evidence about effectiveness and side effects Best at improving HbA1C and blood sugar levels More rapid weight loss may also reduce lean muscle mass Possibly reduced nausea and vomiting Higher cost Requires refrigeration Weight gain common after discontinued use From $139/month LEARN MORE - GLP-1/GIP Agonists (Tirzepatide/Zepbound) SEMAGLUTIDE/WEGOVY Once-weekly injection STEP-1 Trial: Up to 15% mean body weight reduction Good long-term evidence about effectiveness and safety Evidence of reduction in diabetic and heart disease risk Slower weight loss may help maintain lean body mass and reduce gallbladder complications Nausea and vomiting similar to other medications Lower cost than Tirzepatide Requires refrigeration Weight gain common after discontinued use From $139/month LEARN MORE - GLP-1 Agonist (Semaglutide/Wegovy) WEGOVY ORAL PILL Daily oral medication Avoids injections OASIS-4 Trial: Up to 16.6% body weight reduction Similar side effect profile to injectable medications Improved blood sugar control in diabetics and pre-diabetics No refrigeration Weight gain common after discontinued use From $124/month How do I get started with a weight loss evaluation
US$ 20.69
US$ 21.85
US$ 24.66
US$ 25.51
US$ 27.21
US$ 20.69
US$ 23.93
US$ 27.86
US$ 25.17
